{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T14:21:36Z","timestamp":1784211696000,"version":"3.55.0"},"reference-count":103,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T00:00:00Z","timestamp":1606953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015812","name":"Universidad Militar Nueva Granada","doi-asserted-by":"publisher","award":["IMP-CIAS-2924"],"award-info":[{"award-number":["IMP-CIAS-2924"]}],"id":[{"id":"10.13039\/501100015812","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Leishmaniasis is a parasitic morbid\/fatal disease caused by Leishmania protozoa. Twelve million people worldwide are appraised to be currently infected, including ca. two million infections each year, and 350 million people in 88 countries are at risk of becoming infected. In Colombia, cutaneous leishmaniasis (CL) is a public health problem in some tropical areas. Therapeutics is based on traditional antileishmanial drugs, but this practice has several drawbacks for patients. Thus, the search for new antileishmanial agents is a serious need, but the lack of adequately funded research programs on drug discovery has hampered its progress. Some Colombian researchers have conducted different research projects focused on the assessment of the antileishmanial activity of naturally occurring and synthetic compounds against promastigotes and\/or amastigotes. Results of such studies have separately demonstrated important hits and reasonable potential, but a holistic view of them is lacking. Hence, we present the outcome from a systematic review of the literature (under PRISMA guidelines) on those Colombian studies investigating antileishmanials during the last thirty-two years. In order to combine the general efforts aiming at finding a lead against Leishmania panamensis (one of the most studied and incident parasites in Colombia causing CL) and to recognize structural features of representative compounds, fingerprint-based analyses using conventional machine learning algorithms and clustering methods are shown. Abstraction from such a meta-description led to describe some function-determining molecular features and simplify the clustering of plausible isofunctional hits. This systematic review indicated that the Colombian efforts for the antileishmanials discovery are increasingly intensified, though improvements in the followed pathways must be definitively pursued. In this context, a brief discussion about scope, strengths and limitations of such advances and relationships is addressed.<\/jats:p>","DOI":"10.3390\/molecules25235704","type":"journal-article","created":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T20:09:40Z","timestamp":1607026180000},"page":"5704","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Colombian Contributions Fighting Leishmaniasis: A Systematic Review on Antileishmanials Combined with Chemoinformatics Analysis"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8708-411X","authenticated-orcid":false,"given":"Jeysson","family":"S\u00e1nchez-Su\u00e1rez","sequence":"first","affiliation":[{"name":"Bioprospecting Research Group, School of Engineering, Universidad de La Sabana, Ch\u00eda 250001, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4099-6178","authenticated-orcid":false,"given":"Freddy A.","family":"Bernal","sequence":"additional","affiliation":[{"name":"Bioorganic Chemistry Laboratory, Universidad Militar Nueva Granada, Cajic\u00e1 250247, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3553-9749","authenticated-orcid":false,"given":"Ericsson","family":"Coy-Barrera","sequence":"additional","affiliation":[{"name":"Bioorganic Chemistry Laboratory, Universidad Militar Nueva Granada, Cajic\u00e1 250247, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,12,3]]},"reference":[{"key":"ref_1","unstructured":"Pan American Health Organization (2019). Leishmaniases: Epidemiological Report in the Americas, PAHO. Technical Report No. 8-2019."},{"key":"ref_2","unstructured":"Pan American Health Organization (2019). Colombia: Cutaneous and Mucosal Leishmaniasis, PAHO."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"28266","DOI":"10.1038\/srep28266","article-title":"Taxonomy, diversity, temporal and geographical distribution of Cutaneous Leishmaniasis in Colombia: A retrospective study","volume":"6","author":"Ayala","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Montalvo, A.M., Fraga, J., Montano, I., Monzote, L., van der Auwera, G., Mar\u00edn, M., and Muskus, C. (2016). Identificaci\u00f3n molecular de aislamientos cl\u00ednicos de Leishmania spp. procedentes de Colombia con base en el gen hsp70. Biom\u00e9dica, 36.","DOI":"10.7705\/biomedica.v36i2.2688"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1007\/s00436-017-5454-6","article-title":"Detection and identification of Leishmania spp.: Application of two hsp70-based PCR-RFLP protocols to clinical samples from the New World","volume":"116","author":"Montalvo","year":"2017","journal-title":"Parasitol. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"278","DOI":"10.7705\/biomedica.v39i3.4312","article-title":"Geographical distribution of Leishmania species in Colombia, 1985\u20132017","volume":"39","year":"2019","journal-title":"Biom\u00e9dica"},{"key":"ref_7","unstructured":"Pan American Health Organization (2019). Manual of Procedures for Surveillance and Control of Leishmaniasis in the Americas, PAHO."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1080\/15569527.2019.1610887","article-title":"The effect of pentavalent antimonial compounds used in the treatment of cutaneous leishmaniasis on hemogram and biochemical parameters","volume":"38","author":"An","year":"2019","journal-title":"Cutan. Ocul. Toxicol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Lyra, M.R., Passos, S.R.L., Pimentel, M.I.F., Bedoya-Pacheco, S.J., Valete-Rosalino, C.M., Vasconcellos, E.C.F., Antonio, L.F., Saheki, M.N., Salgueiro, M.M., and Santos, G.P.L. (2016). Pancreatic toxicity as an adverse effect induced by meglumine antimoniate therapy in a clinical trial for cutaneous leishmaniasis. Rev. Instit. Med. Trop. S\u00e3o Paulo, 58.","DOI":"10.1590\/S1678-9946201658068"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1590\/abd1806-4841.20198388","article-title":"American tegumentary leishmaniasis: Severe side effects of pentavalent antimonial in a patient with chronic renal failure","volume":"94","author":"Marques","year":"2019","journal-title":"An. Bras. Dermatol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Brito, N.C., Rabello, A., and Cota, G. (2017). Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: A systematic review. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0184777"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug Resistance in Leishmaniasis","volume":"19","author":"Croft","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Ponte-Sucre, A., Gamarro, F., Dujardin, J.-C., Barrett, M.P., L\u00f3pez-V\u00e9lez, R., Garc\u00eda-Hern\u00e1ndez, R., Pountain, A.W., Mwenechanya, R., and Papadopoulou, B. (2017). Drug resistance and treatment failure in leishmaniasis: A 21st century challenge. PLoS Negl. Trop. Dis., 11.","DOI":"10.1371\/journal.pntd.0006052"},{"key":"ref_14","first-page":"216","article-title":"Study of the scientific production on leishmaniasis in Latin America","volume":"9","author":"Osorio","year":"2014","journal-title":"Recent Pat. Anti-Infect. Drug Discov."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/17460441.2020.1696307","article-title":"The impact of chemoinformatics on drug discovery in the pharmaceutical industry","volume":"15","author":"Maggiora","year":"2020","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e25678","DOI":"10.1002\/qua.25678","article-title":"Computational chemistry in drug lead discovery and design","volume":"119","author":"Cavasotto","year":"2019","journal-title":"Int. J. Quantum Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.2174\/1568026619666190121125106","article-title":"Combating Diseases with Computational Strategies Used for Drug Design and Discovery","volume":"18","author":"Makhouri","year":"2019","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Gillet, V.J. (2019). Applications of Chemoinformatics in Drug Discovery. Biomolecular and Bioanalytical Techniques, Wiley.","DOI":"10.1002\/9781119483977.ch2"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41573-019-0024-5","article-title":"Applications of machine learning in drug discovery and development","volume":"18","author":"Vamathevan","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.drudis.2018.05.010","article-title":"Machine learning in chemoinformatics and drug discovery","volume":"23","author":"Lo","year":"2018","journal-title":"Drug Discov. Today"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.csbj.2019.12.006","article-title":"Machine learning applications in drug development","volume":"18","author":"Kaufmann","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2174\/0929867325666181031093702","article-title":"Advanced in Silico Methods for the Development of Anti- Leishmaniasis and Anti-Trypanosomiasis Agents","volume":"27","author":"Halder","year":"2020","journal-title":"Curr. Med. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2174\/1386207318666150803141219","article-title":"Artificial Neural Network Methods Applied to Drug Discovery for Neglected Diseases","volume":"18","author":"Scotti","year":"2015","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1021\/acsinfecdis.5b00093","article-title":"Computer-Aided Drug Discovery Approaches against the Tropical Infectious Diseases Malaria, Tuberculosis, Trypanosomiasis, and Leishmaniasis","volume":"2","author":"Njogu","year":"2016","journal-title":"ACS Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.3389\/fphar.2018.01278","article-title":"Chemoinformatics Strategies for Leishmaniasis Drug Discovery","volume":"9","author":"Ferreira","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3389\/fgene.2019.00368","article-title":"Informatics and Computational Methods in Natural Product Drug Discovery: A Review and Perspectives","volume":"10","author":"Romano","year":"2019","journal-title":"Front. Genet."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"9275","DOI":"10.1039\/C7OB02193C","article-title":"Harnessing the potential of natural products in drug discovery from a cheminformatics vantage point","volume":"15","author":"Rodrigues","year":"2017","journal-title":"Org. Biomol. Chem."},{"key":"ref_28","first-page":"1663","article-title":"The potential role ofin silicoapproaches to identify novel bioactive molecules from natural resources","volume":"9","author":"Orhan","year":"2017","journal-title":"Futur. Med. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Pereira, F., and Aires-De-Sousa, J. (2018). Computational Methodologies in the Exploration of Marine Natural Product Leads. Mar. Drugs, 16.","DOI":"10.3390\/md16070236"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Herrera-Acevedo, C., Scotti, L., Alves, M.F., Diniz, M.D.F.F.M., and Scotti, M.T. (2017). Computer-Aided Drug Design Using Sesquiterpene Lactones as Sources of New Structures with Potential Activity against Infectious Neglected Diseases. Molecules, 22.","DOI":"10.3390\/molecules22010079"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2174\/138955751503150312141854","article-title":"In-silico Analyses of Natural Products on Leishmania Enzyme Targets","volume":"15","author":"Scotti","year":"2015","journal-title":"Mini-Rev. Med. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., and The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med., 6.","DOI":"10.1371\/journal.pmed.1000097"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/S0140-6736(02)09096-7","article-title":"Drug development for neglected diseases: A deficient market and a public-health policy failure","volume":"359","author":"Trouiller","year":"2002","journal-title":"Lancet"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/S0140-6736(15)61340-X","article-title":"Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990\u20132013: Quantifying the epidemiological transition","volume":"386","author":"Murray","year":"2015","journal-title":"Lancet"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jhealeco.2016.01.012","article-title":"Innovation in the pharmaceutical industry: New estimates of R&D costs","volume":"47","author":"Grabowski","year":"2016","journal-title":"J. Health Econ."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e4348","DOI":"10.1136\/bmj.e4348","article-title":"Pharmaceutical research and development: What do we get for all that money?","volume":"345","author":"Light","year":"2012","journal-title":"BMJ"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1021\/acsmedchemlett.0c00446","article-title":"Challenges and Opportunities for Drug Discovery in Developing Countries: The Example of Cutaneous Leishmaniasis","volume":"11","author":"Surur","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ijpddr.2018.09.006","article-title":"Challenges in drug discovery targeting TriTryp diseases with an emphasis on leishmaniasis","volume":"8","author":"Ferreira","year":"2018","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"ref_39","unstructured":"(2020, October 29). Instituto Nacional de Salud Estad\u00edsticas de Vigilancia Rutinaria, Available online: http:\/\/portalsivigila.ins.gov.co\/VigilanciaRutinaria\/rutinaria_2019.xlsx."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.copbio.2010.09.015","article-title":"The structural diversity and promise of antiparasitic marine invertebrate-derived small molecules","volume":"21","author":"Watts","year":"2010","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/S1473-3099(16)30323-1","article-title":"Potential of marine natural products against drug-resistant fungal, viral, and parasitic infections","volume":"17","author":"Abdelmohsen","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Imperatore, C., Gimmelli, R., Persico, M., Casertano, M., Guidi, A., Saccoccia, F., Ruberti, G., Luciano, P., Aiello, A., and Parapini, S. (2020). Investigating the Antiparasitic Potential of the Marine Sesquiterpene Avarone, Its Reduced Form Avarol, and the Novel Semisynthetic Thiazinoquinone Analogue Thiazoavarone. Mar. Drugs, 18.","DOI":"10.3390\/md18020112"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s11101-016-9455-3","article-title":"Natural products from marine invertebrates against Leishmania parasites: A comprehensive review","volume":"15","author":"Oliveira","year":"2016","journal-title":"Phytochem. Rev."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Yamthe, L.R.T., Appiah-Opong, R., Fokou, P.V.T., Nol\u00e9, T., Boyom, F.F., Nyarko, A.K., and Wilson, M. (2017). Marine Algae as Source of Novel Antileishmanial Drugs: A Review. Mar. Drugs, 15.","DOI":"10.3390\/md15110323"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"\u00c1lvarez-Bard\u00f3n, M., P\u00e9rez-Pertejo, Y., Ord\u00f3\u00f1ez, C., Sep\u00falveda-Crespo, D., Carballeira, N.M., Tekwani, B.L., Sankaranarayanan, M., Mart\u00ednez-Valladares, M., Garc\u00eda-Estrada, C., and Reguera, R.M. (2020). Screening Marine Natural Products for New Drug Leads against Trypanosomatids and Malaria. Mar. Drugs, 18.","DOI":"10.3390\/md18040187"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/13880200801968904","article-title":"Antiprotozoal Activity of Ethanol Extracts of SomeBomareaSpecies","volume":"46","author":"Alzate","year":"2008","journal-title":"Pharm. Biol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0378-8741(01)00346-4","article-title":"Antiprotozoal activities of Colombian plants","volume":"78","author":"Weniger","year":"2001","journal-title":"J. Ethnopharmacol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1365-3024.2009.01134.x","article-title":"Antileishmanial and immunomodulatory activity of Xylopia discreta","volume":"31","author":"Lopez","year":"2009","journal-title":"Parasite Immunol."},{"key":"ref_49","first-page":"188","article-title":"Evaluation of the Leishmanicidal Activity of Rutaceae and Lauraceae Ethanol Extracts on Golden Syrian Hamster (Mesocricetus auratus) Peritoneal Macrophages","volume":"76","author":"Enciso","year":"2014","journal-title":"Indian J. Pharm. Sci."},{"key":"ref_50","first-page":"68","article-title":"Toxicidad, genotoxicidad y actividad anti-Leishmania de aceites esenciales obtenidos de cuatro (4) quimiotipos del g\u00e9nero Lippia","volume":"17","author":"Neira","year":"2018","journal-title":"Bol. Latinoam. Caribe Plantas Med. Aromat."},{"key":"ref_51","first-page":"478","article-title":"Leishmanicidal activity of Annona aff. spraguei seeds","volume":"69","author":"Saez","year":"1998","journal-title":"Fitoterapia"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0367-326X(99)00138-0","article-title":"Cytotoxicity and antileishmanial activity of Annona muricata pericarp","volume":"71","author":"Jaramillo","year":"2000","journal-title":"Fitoterapia"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jep.2007.01.015","article-title":"Antiprotozoal and cytotoxic activities in vitro of Colombian Annonaceae","volume":"111","author":"Osorio","year":"2007","journal-title":"J. Ethnopharmacol."},{"key":"ref_54","first-page":"350","article-title":"Actividad in vitro de la mezcla de alcaloides de Ervatamia coronaria (Jacq) Staff. Apocynaceae sobre amastigotes de Leishmania braziliensis","volume":"18","author":"Camargo","year":"2008","journal-title":"Rev. Bras. Farm."},{"key":"ref_55","first-page":"131","article-title":"Evaluaci\u00f3n in vitro de la actividad de aceites esenciales de plantas colombianas sobre Leishmania Brazilien","volume":"38","author":"Robledo","year":"2009","journal-title":"Rev. Colomb. Cienc. Quim. Farm"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jep.2009.03.041","article-title":"Medicinal plants from the Yanesha (Peru): Evaluation of the leishmanicidal and antimalarial activity of selected extracts","volume":"123","author":"Adriana","year":"2009","journal-title":"J. Ethnopharmacol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3109\/13880200903193344","article-title":"Screening of Latin American plants for antiparasitic activities against malaria, Chagas disease, and leishmaniasis","volume":"48","author":"Calderon","year":"2010","journal-title":"Pharm. Biol."},{"key":"ref_58","first-page":"63","article-title":"In vitro studies on the relationship between the anti-inflammatory activity of Physalis peruviana extracts and the phagocytic process","volume":"32","author":"Ospina","year":"2009","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"ref_59","first-page":"129","article-title":"Evaluation of the Leishmanicidal and Cytotoxic Potential of Essential Oils Derived from Ten Colombian Plants","volume":"8","author":"Riveros","year":"2013","journal-title":"Iran. J. Parasitol."},{"key":"ref_60","first-page":"268","article-title":"Leishmanicidal and antioxidant activity of extracts of Piper daniel-gonzalezii trel. (piperaceae)","volume":"18","author":"Rojano","year":"2013","journal-title":"Rev. Cubana Plantas Med."},{"key":"ref_61","first-page":"208","article-title":"Perfil fitoqu\u00edmico, actividad anti-Leishmania, hemol\u00edtica y toxicol\u00f3gica de Cordia dentata Poir. y Heliotropium indicum L.","volume":"19","year":"2014","journal-title":"Rev. Cubana Plantas Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1590\/0037-8682-0457-2016","article-title":"In vitro and in vivo antileishmanial activity of Artemisia annua L. leaf powder and its potential usefulness in the treatment of uncomplicated cutaneous leishmaniasis in humans","volume":"50","author":"Mesa","year":"2017","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4067\/S0718-07642018000300177","article-title":"Estudio Fitoqu\u00edmico y Evaluaci\u00f3n de la Actividad Antioxidante y Leishmanicida de la Especie Pilocarpus alvaradoi (Rutaceae)","volume":"29","author":"Marin","year":"2018","journal-title":"Inform. Tecnol."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Robledo, S., Velez, I.D., and Schmidt, T.J. (2018). Arnica Tincture Cures Cutaneous Leishmaniasis in Golden Hamsters. Molecules, 23.","DOI":"10.3390\/molecules23010150"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.actatropica.2017.09.033","article-title":"Evaluating the anti-leishmania activity of Lucilia sericata and Sarconesiopsis magellanica blowfly larval excretions\/secretions in an in vitro model","volume":"177","author":"Echeverry","year":"2018","journal-title":"Acta Trop."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ab.2018.01.029","article-title":"Identification and evaluation of Galleria mellonella peptides with antileishmanial activity","volume":"546","year":"2018","journal-title":"Anal. Biochem."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e00379","DOI":"10.1016\/j.btre.2019.e00379","article-title":"Enzymatic, antimicrobial, and leishmanicidal bioactivity of gram-negative bacteria strains from the midgut of Lutzomyia evansi, an insect vector of leishmaniasis in Colombia","volume":"24","author":"Vivero","year":"2019","journal-title":"Biotechnol. Rep."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Patino, L.H., Mendez, C., Rodriguez, O., Romero, Y., Velandia, D., Alvarado, M., P\u00e9rez, J., Duque, M.C., and Ram\u00edrez, J.D. (2017). Spatial distribution, Leishmania species and clinical traits of Cutaneous Leishmaniasis cases in the Colombian army. PLoS Negl. Trop. Dis., 11.","DOI":"10.1371\/journal.pntd.0005876"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Ovalle-Bracho, C., Londo\u00f1o-Barbosa, D., Salgado-Almario, J., and Gonz\u00e1lez, C. (2019). Evaluating the spatial distribution of Leishmania parasites in Colombia from clinical samples and human isolates (1999 to 2016). PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0214124"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1016\/S0035-9203(02)90063-5","article-title":"Drug sensitivity of Leishmania species: Some unresolved problems","volume":"96","author":"Croft","year":"2002","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Alc\u00e2ntara, L.M., Ferreira, T.C., Fontana, V., Chatelain, E., Moraes, C.B., and Freitas-Junior, L.H. (2020). A Multi-Species Phenotypic Screening Assay for Leishmaniasis Drug Discovery Shows That Active Compounds Display a High Degree of Species-Specificity. Molecules, 25.","DOI":"10.3390\/molecules25112551"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ejmech.2016.06.004","article-title":"Synthesis and antileishmanial activity of C7- and C12-functionalized dehydroabietylamine derivatives","volume":"121","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ejmech.2017.04.044","article-title":"An overview of azoles targeting sterol 14\u03b1-demethylase for antileishmanial therapy","volume":"135","author":"Emami","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40409-018-0174-7","article-title":"Second-generation pterocarpanquinones: Synthesis and antileishmanial activity","volume":"24","author":"Barcellos","year":"2018","journal-title":"J. Venom. Anim. Toxins Incl. Trop. Dis."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez, O.L., Diaz-Toro, Y., Ovalle, C., Valderrama, L., Muvdi, S., Rodr\u00edguez, I., Gomez, M.A., and Saravia, N.G. (2014). Miltefosine and Antimonial Drug Susceptibility of Leishmania viannia Species and Populations in Regions of High Transmission in Colombia. PLoS Negl. Trop. Dis., 8.","DOI":"10.1371\/journal.pntd.0002871"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Franco-Mu\u00f1oz, C., Manjarr\u00e9s-Estremor, M., and Ovalle-Bracho, C. (2018). Intraspecies differences in natural susceptibility to amphotericine B of clinical isolates of Leishmania subgenus Viannia. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0196247"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.pt.2016.11.003","article-title":"Exploiting Knowledge on Leishmania Drug Resistance to Support the Quest for New Drugs","volume":"33","author":"Hefnawy","year":"2017","journal-title":"Trends Parasitol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.exppara.2009.02.012","article-title":"Leishmania (Viannia) panamensis: An in vitro assay using the expression of GFP for screening of antileishmanial drug","volume":"122","author":"Robledo","year":"2009","journal-title":"Exp. Parasitol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1021\/ci500588j","article-title":"DataWarrior: An Open-Source Program for Chemistry Aware Data Visualization and Analysis","volume":"55","author":"Sander","year":"2015","journal-title":"J. Chem. Inf. Model."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nrd4683","article-title":"Hit and lead criteria in drug discovery for infectious diseases of the developing world","volume":"14","author":"Katsuno","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_81","unstructured":"(2011). MACCS Structural Keys, Accelrys."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1021\/c160017a018","article-title":"The Generation of a Unique Machine Description for Chemical Structures-A Technique Developed at Chemical Abstracts Service","volume":"5","author":"Morgan","year":"1965","journal-title":"J. Chem. Doc."},{"key":"ref_83","unstructured":"(2020, May 21). RDKit: Cheminformatics and Machine Learning Software. Available online: http:\/\/rdkit.org."},{"key":"ref_84","first-page":"2579","article-title":"Visualizing Data using t-SNE","volume":"9","author":"Hinton","year":"2008","journal-title":"J. Mach. Learn. Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.drudis.2009.01.012","article-title":"Healthy skepticism: Assessing realistic model performance","volume":"14","author":"Brown","year":"2009","journal-title":"Drug Discov. Today"},{"key":"ref_86","unstructured":"Lundberg, S.M., and Lee, S.-I. (2017, January 4\u20139). A Unified Approach to Interpreting Model Predictions. Proceedings of the 31st International Conference on Neural Information Processing Systems, Systems (NIPS 2017), Long Beach, California, USA."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s42256-019-0138-9","article-title":"From local explanations to global understanding with explainable AI for trees","volume":"2","author":"Lundberg","year":"2020","journal-title":"Nat. Mach. Intell."},{"key":"ref_88","first-page":"8761","article-title":"Interpretation of Compound Activity Predictions from Complex Machine Learning Models Using Local Approximations and Shapley Values","volume":"63","author":"Bajorath","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s10822-020-00314-0","article-title":"Interpretation of machine learning models using shapley values: Application to compound potency and multi-target activity predictions","volume":"34","author":"Bajorath","year":"2020","journal-title":"J. Comput. Mol. Des."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1093\/bioinformatics\/btx491","article-title":"FAF-Drugs4: Free ADME-tox filtering computations for chemical biology and early stages drug discovery","volume":"33","author":"Lagorce","year":"2017","journal-title":"Bioinformatics"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejmech.2019.03.007","article-title":"Structure-activity relationships and mechanistic studies of novel mitochondria-targeted, leishmanicidal derivatives of the 4-aminostyrylquinoline scaffold","volume":"171","author":"Staderini","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.1016\/j.bmc.2003.09.007","article-title":"Synthesis and biological evaluation of substituted quinolines: Potential treatment of protozoal and retroviral co-infections","volume":"11","author":"Fakhfakh","year":"2003","journal-title":"Bioorg. Med. Chem."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2147\/CLEP.S43118","article-title":"Titles versus titles and abstracts for initial screening of articles for systematic reviews","volume":"5","author":"Mateen","year":"2013","journal-title":"Clin. Epidemiol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014A web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst. Rev."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/17460441.2019.1581170","article-title":"DataWarrior: An evaluation of the open-source drug discovery tool","volume":"14","author":"Naveja","year":"2019","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1021\/ci100050t","article-title":"Extended-Connectivity Fingerprints","volume":"50","author":"Rogers","year":"2010","journal-title":"J. Chem. Inf. Model."},{"key":"ref_97","first-page":"2825","article-title":"Scikit-learn: Machine Learning in Python","volume":"12","author":"Pedregosa","year":"2011","journal-title":"J. Mach. Learn. Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random Forests","volume":"45","author":"Breiman","year":"2001","journal-title":"Mach. Learn."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1080\/21642583.2014.956265","article-title":"Random forests: From early developments to recent advancements","volume":"2","author":"Fawagreh","year":"2014","journal-title":"Syst. Sci. Control. Eng."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1093\/bioinformatics\/bty373","article-title":"The revival of the Gini importance?","volume":"34","author":"Nembrini","year":"2018","journal-title":"Bioinformatics"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1023\/B:STCO.0000035301.49549.88","article-title":"A tutorial on support vector regression","volume":"14","author":"Smola","year":"2004","journal-title":"Stat. Comput."},{"key":"ref_102","first-page":"307","article-title":"A value for n-person games","volume":"Volume 2","author":"Kuhn","year":"1953","journal-title":"Contributions to the Theory of Games"},{"key":"ref_103","unstructured":"Lundberg, S.M. (2020, October 29). A Game Theoretic Approach to Explain the Output of Any Machine Learning Model. Available online: https:\/\/github.com\/slundberg\/shap#citations."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/25\/23\/5704\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:41:01Z","timestamp":1760179261000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/25\/23\/5704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,3]]},"references-count":103,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["molecules25235704"],"URL":"https:\/\/doi.org\/10.3390\/molecules25235704","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,3]]}}}